370 related articles for article (PubMed ID: 32080856)
1. Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma.
Jutel M; Brüggenjürgen B; Richter H; Vogelberg C
Allergy; 2020 Aug; 75(8):2050-2058. PubMed ID: 32080856
[TBL] [Abstract][Full Text] [Related]
2. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
Jutel M; Klimek L; Richter H; Brüggenjürgen B; Vogelberg C
Allergy; 2024 Apr; 79(4):1042-1051. PubMed ID: 38429981
[TBL] [Abstract][Full Text] [Related]
3. Real-World Safety and Effectiveness Evidence of a Microcrystalline Tyrosine-Associated Mite Allergoid in Children and Adolescents with Allergic Rhinitis.
Anna SC; Zulay M AS; Ignacio GN; Sofia L; Juan A MT; Maria D M; Ramón N; Mercedes R; Anna B; Carla TB; José L J
Allergol Immunopathol (Madr); 2021; 49(4):98-108. PubMed ID: 34224224
[TBL] [Abstract][Full Text] [Related]
4. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
Wahn U; Bachert C; Heinrich J; Richter H; Zielen S
Allergy; 2019 Mar; 74(3):594-604. PubMed ID: 30183091
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
Vogelberg C; Klimek L; Kruppert S; Becker S
Clin Exp Allergy; 2024 Apr; 54(4):253-264. PubMed ID: 38146840
[TBL] [Abstract][Full Text] [Related]
6. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
Heldner A; Alessandrini F; Russkamp D; Heine S; Schnautz B; Chaker A; Mwange J; Carreno Velazquez TL; Heath MD; Skinner MA; Kramer MF; Zissler UM; Schmidt-Weber CB; Blank S
Allergy; 2022 Mar; 77(3):907-919. PubMed ID: 34287971
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study.
Padró C; Gutiérrez D; Moreno F; Parra A; Rial MJ; Lleonart R; Torán-Barona C; Justicia JL; Roger A
Immun Inflamm Dis; 2022 May; 10(5):e585. PubMed ID: 35478444
[TBL] [Abstract][Full Text] [Related]
8. House dust mite subcutaneous immunotherapy has sustained long-term effectiveness on allergic rhinitis and asthma: A 10-year follow-up.
Rodriguez-Plata E; Callero Viera A; Ruiz-Garcia M; Gomez-Cardenosa A; Nieto E; García-Robaina JC
Immun Inflamm Dis; 2023 Oct; 11(10):e1004. PubMed ID: 37904678
[TBL] [Abstract][Full Text] [Related]
9. Specific immunotherapy for rhinitis and asthma with a subcutaneous hypoallergenic high-dose house dust mite extract: results of a 9-month therapy.
El-Qutob D; Moreno F; Subtil-Rodríguez A
Immunotherapy; 2016 Jul; 8(8):867-76. PubMed ID: 27188493
[TBL] [Abstract][Full Text] [Related]
10. Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.
Vogelberg C; Brüggenjürgen B; Richter H; Jutel M
Patient Prefer Adherence; 2020; 14():817-827. PubMed ID: 32494127
[TBL] [Abstract][Full Text] [Related]
11. Safety and effectiveness of a microcrystalline tyrosine-associated mite extract immunotherapy for allergic rhinitis.
Sala-Cunill A; Pérez-Formoso JL; Torán-Barona C; Almeida-Sánchez ZM; Álvarez-Fernández JA; García-Núñez I; Linana-Santafé JJ; Martínez-Tadeo JA; Boronat-Barado A; Justicia JL
Immunotherapy; 2020 Sep; 12(13):1007-1019. PubMed ID: 32811270
[No Abstract] [Full Text] [Related]
12. [DIFFERENCE BETWEEN STANDARDIZED MITE ANTIGEN AND HOUSE DUST EXTRACT IN RUSH SUBCUTANEOUS IMMUNOTHERAPY FOR CHILDREN].
Tanaka Y; Okafuji I; Omae S; Mitobe Y; Doi K; Tsuruta S
Arerugi; 2019; 68(6):681-690. PubMed ID: 31308334
[TBL] [Abstract][Full Text] [Related]
13. Impact of house dust mite-driven asthma on children's school performance and activity.
Gómez C; Barrena J; García-Paz V; Plaza AM; Crespo P; Bejarano JA; Rodríguez AB; Ferré L; Farrarons L; Viñas M; Torán-Barona C; Pereiro A; Justicia JL; Nevot S
Eur J Pediatr; 2022 Apr; 181(4):1567-1574. PubMed ID: 34935084
[TBL] [Abstract][Full Text] [Related]
14. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
Richards JR; Stumpf JL
Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
[TBL] [Abstract][Full Text] [Related]
15. Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases.
Yang Y; Ma D; Huang N; Li W; Jiang Q; Wang Y; Wang X; Yang L; Zhu R
Ital J Pediatr; 2021 Apr; 47(1):101. PubMed ID: 33892756
[TBL] [Abstract][Full Text] [Related]
16. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
Fritzsching B; Contoli M; Porsbjerg C; Buchs S; Larsen JR; Elliott L; Rodriguez MR; Freemantle N
Lancet Reg Health Eur; 2022 Feb; 13():100275. PubMed ID: 34901915
[TBL] [Abstract][Full Text] [Related]
17. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study.
Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B
J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma.
Farraia M; Paciência I; Castro Mendes F; Cavaleiro Rufo J; H Shamji M; Agache I; Moreira A
Allergy; 2022 Sep; 77(9):2688-2698. PubMed ID: 35451128
[TBL] [Abstract][Full Text] [Related]
20. [Observation and analysis of systemic reactions to house dust mite subcutaneous immunotherapy in 362 patients with allergic rhinitis].
Xue JR; Ma J; Qiu CY; Hu ZB; Jiang X; Pan M; Lu MP; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):445-451. PubMed ID: 32842357
[No Abstract] [Full Text] [Related]
[Next] [New Search]
